The EMA has expanded the coverage of its pharmacovigilance website, to allow patients, the public and healthcare professionals to report suspected side effects encountered with any nationally-authorised medicine.
The EMA’s website, www.adrreports.eu, was previously only used for centrally-registered medicines. The inclusion of all nationally-authorised medicines will add another 1,700 substances to the register.
Once reported via the website, the information is added to the EudraVigilance database. As you’d expect, patients accessing the site are strongly advised to seek the advice of and notify their healthcare professional if they are experiencing any adverse drug reactions.
In addition to filing reports on suspected problems with medicines, the site also lets the public obtain information on suspected adverse drug reactions - ie, those that have been reported but may not be related to, or caused by, the medicine.
Last year, EudraVigilance received 35,600 patient reports.
|
|
 |
|
|
Share on LinkedIn |
Share via Email |
